Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes
Diabetes is the most common cause of CKD (chronic kidney disease). CKD is also one of the most important diabetic complication. SGLT2 (sodium glucose co‐transporter‐2) inhibitors are new class of medication used to lower high blood glucose level in people with type 2 diabetes. In new researches SGL...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Kazimierz Wielki University
2022-09-01
|
| Edice: | Journal of Education, Health and Sport |
| Témata: | |
| On-line přístup: | https://apcz.umk.pl/JEHS/article/view/39675 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|